FEIM:NASDAQFrequency Electronics, Inc. Analysis
Data as of 2026-04-02 - not real-time
$49.24
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Frequency Electronics is trading at $49.24, just below its 50‑day SMA of 49.50 but above the 20‑day SMA of 46.63, indicating a modest short‑term pullback within a neutral trend. The MACD histogram is positive (0.45) and the signal line is bullish, while the RSI sits at 54, suggesting no immediate overbought or oversold condition. Volatility is extremely high at roughly 94% over the past 30 days and the computed beta of 1.37 points to sensitivity above the market. Fundamentally, the stock carries a steep PE of 67 versus an industry average of 33, a PB of 8, and a price‑to‑sales of 7, flagging significant overvaluation. Revenue has contracted 10.8% year‑over‑year to $67.8 M and margins are thin (gross 38%, operating 7.5%, profit 10.6%). Cash generation is negative, with operating cash flow of –$0.93 M and free cash flow of –$7.09 M, while debt stands at $8.13 M on a modest equity base, yielding a debt‑to‑equity of 13.5.
Recent earnings disclosed a further revenue dip to $16.9 M for Q3 FY26 and margin pressure, yet management highlighted a growing backlog and newly awarded contracts worth about $45 M, which could bolster future top‑line growth. The market sentiment index reads “Extreme Greed” at 78.8, but the stock has underperformed since the earnings release, falling 11.4% and lagging the S&P 500. The upside/downside estimate suggests roughly a 20% upside to a target of $59, tempered by cash‑flow weakness and high valuation multiples.
Recent earnings disclosed a further revenue dip to $16.9 M for Q3 FY26 and margin pressure, yet management highlighted a growing backlog and newly awarded contracts worth about $45 M, which could bolster future top‑line growth. The market sentiment index reads “Extreme Greed” at 78.8, but the stock has underperformed since the earnings release, falling 11.4% and lagging the S&P 500. The upside/downside estimate suggests roughly a 20% upside to a target of $59, tempered by cash‑flow weakness and high valuation multiples.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Earnings miss and margin pressure
- High valuation multiples relative to peers
- Neutral technical setup with modest bullish MACD
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- New $45 M contract awards expanding backlog
- Estimated upside to $59 (~20% potential)
- Bullish MACD histogram and stable volume
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Sustained overvaluation and weak cash flow generation
- High debt load relative to equity
- Sector cyclicality and exposure to defense spending
Key Metrics & Analysis
Financial Health
Revenue Growth-10.80%
Profit Margin10.62%
P/E Ratio67.5
ROE12.85%
ROA4.59%
Debt/Equity13.49
P/B Ratio8.0
Op. Cash Flow$-934000
Free Cash Flow$-7091000
Industry P/E33.5
Technical Analysis
TrendNeutral
RSI54.0
Support$39.80
Resistance$56.74
MA 20$46.63
MA 50$49.50
MA 200$37.72
MACDBullish
VolumeStable
Fear & Greed Index78.8
Valuation
Target Price$59.00
Upside/Downside19.82%
GradeOvervalued
TypeValue
Risk Assessment
Beta1.37
Volatility93.98%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.